Explorer›Chikungunya›Open Science
Research PaperResearchia:202602.16024

Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis

A. Gervais

Abstract

Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis --- Source: OpenAlex - Proceedings of the National Academy of Sciences (Citations: 2) PDF: https://www.pnas.org/doi/pdf/10.1073/pnas.2532212123 Original Link: https://doi.org/https://doi.org/10.1073/pnas.2532212123

Submitted: February 16, 2026Subjects: Open Science; Chikungunya

Description / Details

Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis

Source: OpenAlex - Proceedings of the National Academy of Sciences (Citations: 2) PDF: https://www.pnas.org/doi/pdf/10.1073/pnas.2532212123 Original Link: https://doi.org/https://doi.org/10.1073/pnas.2532212123

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper
View Source PDF
Submission Info
Date:
Feb 16, 2026
Topic:
Chikungunya
Area:
Open Science
Comments:
0
Bookmark
Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis | Researchia